Cano Health, Inc.
CANO
CANO was delisted on the 2nd of February, 2024.
146 hedge funds and large institutions have $980M invested in Cano Health, Inc. in 2022 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 53 increasing their positions, 41 reducing their positions, and 21 closing their positions.
298% more call options, than puts
Call options by funds: $25.1M | Put options by funds: $6.32M
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
76% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 21
29% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 41
12% more funds holding
Funds holding: 130 → 146 (+16)
32% less capital invested
Capital invested by funds: $1.43B → $980M (-$453M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$28.9M |
| 2 |
OCAM
Owl Creek Asset Management
New York
|
+$17M |
| 3 |
Barclays
London,
United Kingdom
|
+$14.9M |
| 4 |
Millennium Management
New York
|
+$14.8M |
| 5 |
D.E. Shaw & Co
New York
|
+$12.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$41.7M |
| 2 |
SCM
Suvretta Capital Management
New York
|
-$39.1M |
| 3 |
EC
Eminence Capital
New York
|
-$35.2M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$26.1M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$18.8M |
CANO Hedge Fund Activity: Q1 2022 in Review
146 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Cano Health, Inc. (CANO) for Q1 2022, worth a combined $980M — down 32% from $1.43B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new CANO positions and 21 closed out — a net gain of 16 holders — while 53 added to existing stakes and 41 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $28.9M. The largest seller was Capital World Investors, cutting an estimated $41.7M.
- 146 institutional investors held Cano Health, Inc. (CANO) as of Q1 2022, up from 130 in Q4 2021.
- Funds reported $980M of Cano Health, Inc. stock for Q1 2022, down 32% quarter-over-quarter.
- 37 funds opened new Cano Health, Inc. positions in Q1 2022 and 21 closed out, a net change of +16 holders.
- The largest Cano Health, Inc. buyer in Q1 2022 was JP Morgan Chase, an estimated $28.9M added.
- The largest Cano Health, Inc. seller in Q1 2022 was Capital World Investors, an estimated $41.7M sold.
Based on aggregated 13F filings for Q1 2022.